These findings are consistent with the study results that showed that podocyte-specific genetic deletion of Notch1 resulted in amelioration of diabetic nephropathy, while genetic deletion of Notch2 in podocytes did not affect microalbuminuria and the progression of DKD [44]. The gene discussed is NOTCH1; the disease is diabetic kidney disease.